PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $490,000 | -30.2% | 69,590 | -23.6% | 0.04% | -32.8% |
Q4 2014 | $702,000 | +110.2% | 91,089 | +103.5% | 0.06% | +100.0% |
Q3 2014 | $334,000 | -2.6% | 44,767 | +26.4% | 0.03% | -5.9% |
Q2 2014 | $343,000 | +1.8% | 35,407 | -12.6% | 0.03% | -8.1% |
Q1 2014 | $337,000 | +17.8% | 40,502 | +19.7% | 0.04% | +12.1% |
Q4 2013 | $286,000 | -41.3% | 33,848 | -44.6% | 0.03% | -48.4% |
Q3 2013 | $487,000 | +3.4% | 61,064 | 0.0% | 0.06% | -4.5% |
Q2 2013 | $471,000 | – | 61,064 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |